Home > > > > Report Detail

Electronic Drug Delivery Systems Market by Type (Electronic Wearable Infusion Pump, Autoinjectors, Injection Pens, Electronic Inhalers), Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD) - Global Forecast to 2024

Publisher Name :
Date: 15-Oct-2019
No. of pages: 125
Inquire Before Buying

“The electronic drug delivery systems market is projected to grow at a CAGR of 8.7% during the forecast period (2019–2024).”

The electronic drug delivery systems market is projected to reach USD 11.9 billion by 2024 from USD 7.8 billion in 2019, at a CAGR of 8.7%. The growth of the electronic drug delivery systems market is mainly driven by the favorable reimbursement scenario in North America & Europe, the growing prevalence of target diseases such as diabetes & cardiovascular disease, and advancements in technologies and designs of electronic drug delivery systems. Additionally, emerging markets such as China and India are expected to offer potential growth opportunities to market players in the coming years.

By type, the electronic wearable infusion pumps segment is expected to account for the largest share of the electronic drug delivery systems market

Based on type, the electronic drug delivery systems market is segmented into electronic wearable infusion pumps, electronic auto injectors, electronic injection pens, and electronic inhalers. The electronic wearable infusion pumps segment is expected to account for the largest market share of the electronic drug delivery systems market in 2019. This is mainly due to the high prevalence of diabetes and the increasing availability of commercial infusion pumps for diabetes treatment.

By indication, the diabetes segment is to dominate the electronic drug delivery systems market during the forecast period

The diabetes segment accounted for the largest share of the market in 2018. This is mainly due to the high availability of electronic drug delivery devices such as insulin pumps and injection pens by major market players in comparison to other therapeutic areas, rising adoption of mobile apps for diabetes management, and increasing penetration of digital platforms (such as smartphones, tablet PCs, and personal digital assistants).For instance, in June 2018, Insulet Corporation (US), received the FDA approval for its Omnipod DASH Insulin Management System for diabetes management. Similarly, in June 2018, Tandem Diabetes Care (US), received the CE mark for its t:slim X2 Insulin Pump for diabetes management.

“North America is expected to witness the highest growth during the forecast period.”

North America is expected to account for the largest share of the global electronic drug delivery system market in 2019, followed by Europe. Additionally, the US is also expected to witness the highest CAGR during the forecast period. This can primarily be attributed to the high incidence and prevalence of chronic conditions such as diabetes, asthma, CVD, and multiple sclerosis in the US. For instance, according to the IDF, there were about 30.2 million people suffering from diabetes in the US in 2017, and this figure is estimated to reach 35.6 million by 2045. Similarly, in 2017, approximately 25.2 million people had asthma in the US (Source:CDC). Furthermore, According to the American Heart Association, in 2017, about 801,000 deaths in the US are due to CVD. Obesity is a major risk factor for CVD and diabetes in the US; around 36.5% of adults in the country are obese (Source: CDC).

A breakdown of the primary participants referred to for this report is provided below:


  • By Company Type: Tier 1–21%, Tier 2–26%, and Tier 3–53%

  • By Designation: C-level–32%, Director-level–26%, and Others–42%

  • By Region: North America–35%, Europe–30%, Asia Pacific–15%,Latin America–10%, Middle East & Africa–10%


The prominent players in the electronic drug delivery systems market are United Therapeutics Corporation (US), Insulet Corporation (US), Novo Nordisk (Denmark), Bayer AG (Germany), Medtronic plc (Ireland), AstraZeneca (UK), Tandem Diabetes Care (US), Merck Group (Germany), and Amgen (US).

Research Coverage:

The report analyzes the electronic drug delivery system market and aims at estimating the market size and future growth potential of the electronic drug delivery systems market and the different segments such as diabetes, multiple sclerosis, cardiovascular disease, asthma & COPD, and other indications (growth hormone therapy, primary immunodeficiency disease, thalassemia, and Parkinson’s disease). The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product& service offerings, and recent developments.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:


  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the electronic drug delivery system market.

  • Product & Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product or service launch in the electronic drug delivery system market.

  • Market Development: Comprehensive information on lucrative emerging regions.

  • Market Diversification: Exhaustive information about new products and services, growing geographies, and recent developments in the global electronic drug delivery system market.

  • Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products& services of the leading players in the electronic drug delivery system market.

Electronic Drug Delivery Systems Market by Type (Electronic Wearable Infusion Pump, Autoinjectors, Injection Pens, Electronic Inhalers), Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD) - Global Forecast to 2024

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Research
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Research
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Market Size Estimation
2.3 Data Triangulation Approach
2.4 Market Share Analysis
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Electronic Drug Delivery Systems: Market Overview
4.2 North America: Market, By Type, 2018
4.3 Geographical Snapshot of the Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Prevalence of Target Diseases
5.2.1.2 Favorable Reimbursement Scenario in Major Markets
5.2.1.3 Advancements in Technologies and Designs
5.2.2 Restraints
5.2.2.1 Preference for Alternative Drug Delivery Modes and the Possibility of Errors
5.2.3 Opportunities
5.2.3.1 Increasing Demand for Biologics and Mabs
5.2.3.2 Growth Opportunities in Emerging Markets
5.2.4 Challenges
5.2.4.1 Unfavorable Reimbursement Structure in Developing Countries

6 Market, By Type
6.1 Introduction
6.1.1 Electronic Wearable Infusion Pumps
6.1.1.1 Electronic Wearable Infusion Pumps Dominate the Market
6.1.2 Electronic Autoinjectors
6.1.2.1 Electronic Autoinjectors are Likely to Register Negative Growth During the Forecast Period Due to the Continuous Influx of Generic Versions of Conventional Autoinjectors in the Market
6.1.3 Electronic Injection Pens
6.1.3.1 Growing Focus of Pharmaceutical Companies on Developing Electronic/Connected Injection Pens Will Drive Market Growth
6.1.4 Electronic Inhalers
6.1.4.1 Electronic Inhalers are Developed to Improve Medication Adherence in Asthma & COPD Management

7 Market, By Indication
7.1 Introduction
7.2 Diabetes
7.2.1 Diabetes Accounted for the Largest Segment of the Market
7.3 Multiple Sclerosis
7.3.1 Launch of Generic Versions of Conventional Injectables Will Stifle Market Growth
7.4 Cardiovascular Disease
7.4.1 Development of Innovative Electronic Drug Delivery Systems for Cvd Treatment Will Drive Market Growth
7.5 Asthma & COPD
7.5.1 Development of Smart Inhalers and Digital Sensors is Likely to Improve Medication Adherence in Asthma & COPD Patients
7.6 Other Indications

8 Market, By Region
8.1 Introduction
8.2 North America
8.2.1 US
8.2.1.1 The US has A Favorable Reimbursement Scenario for Electronic Drug Delivery Devices, Which is A Key Factor Driving the Market for Electronic Drug Delivery Systems
8.2.2 Canada
8.2.2.1 Growing Presence of Device Manufacturers in the Country is Expected to Propel Market Growth
8.3 Europe
8.3.1 Germany
8.3.1.1 Germany is the Largest Market for Electronic Drug Delivery Systems in Europe
8.3.2 UK
8.3.2.1 High Burden of Target Diseases to Support Market Growth
8.3.3 France
8.3.3.1 High Prevalence of Diabetes in the Country to Propel Market Growth
8.3.4 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.1.1 Large Geriatric Population and the High Prevalence of Cvd to Support Market Growth
8.4.2 China
8.4.2.1 Growing Focus of Major Players on Biologics Development to Drive Market Growth
8.4.3 India
8.4.3.1 Lack of Reimbursement and Guidelines on Electronic Drug Delivery Systems Could Limit Market Growth
8.4.4 RoAPAC
8.5 Rest of the World
8.5.1 Latin America
8.5.1.1 High Incidence of Chronic Diseases to Drive the Demand for Electronic Drug Delivery Systems
8.5.2 Middle East & Africa
8.5.2.1 Favorable Reforms in South Africa to Support Market Growth

9 Competitive Landscape
9.1 Overview
9.2 Market Share Analysis
9.3 Key Player Analysis
9.3.1 Merck Group
9.3.2 Medtronic PLC
9.4 Competitive Scenario
9.4.1 Product Launches
9.4.2 Expansions
9.4.3 Agreements & Collaborations
9.5 Competitive Leadership Mapping (2018)
9.5.1 Visionary Leaders
9.5.2 Innovators
9.5.3 Dynamic Differentiators
9.5.4 Emerging Companies

10 Company Profiles
10.1 Merck Group
10.1.1 Business Overview
10.1.2 Products Offered
10.1.3 Recent Developments
10.2 Medtronic PLC
10.2.1 Business Overview
10.2.2 Products Offered
10.2.3 Recent Developments
10.3 United Therapeutics Corporation
10.3.1 Business Overview
10.3.2 Products Offered
10.3.3 Recent Developments
10.4 Insulet Corporation
10.4.1 Business Overview
10.4.2 Products Offered
10.4.3 Recent Developments
10.5 Bayer AG
10.5.1 Business Overview
10.5.2 Products Offered
10.5.3 Recent Developments
10.6 Novo Nordisk
10.6.1 Business Overview
10.6.2 Products Offered
10.6.3 Recent Developments
10.7 Companion Medical
10.7.1 Business Overview
10.7.2 Products Offered
10.7.3 Recent Developments
10.8 Tandem Diabetes Care, Inc.
10.8.1 Business Overview
10.8.2 Products Offered
10.8.3 Recent Developments
10.9 F.Hoffmann-La Roche, Ltd.
10.9.1 Business Overview
10.9.2 Products Offered
10.9.3 Recent Developments
10.10 Amgen, Inc.
10.10.1 Business Overview
10.10.2 Products Offered
10.10.3 Recent Developments
10.11 Astrazeneca PLC
10.11.1 Business Overview
10.11.2 Products Offered
10.11.3 Recent Developments
10.12 Findair SP. Z O. O.
10.12.1 Business Overview
10.12.2 Products Offered
10.12.3 Recent Developments
10.13 Vicentra B.V.
10.13.1 Business Overview
10.13.2 Products Offered
10.13.3 Recent Developments
10.14 Canè SPA
10.14.1 Business Overview
10.14.2 Products Offered
10.15 Debiotech S.A.
10.15.1 Business Overview
10.15.2 Products Offered

11 Appendix
11.1 Discussion Guide
11.2 Knowledge Store: Marketsandmarkets’  Subscription Portal
11.3 Related Reports
11.4 Author Details

List of Tables

Table 1 Commercially Available Biologics as Potential Applications for Electronic Drug Delivery Systems in the Coming Years
Table 2 Market, By Type, 2017–2024 (usD Million)
Table 3 Electronic Drug Delivery Systems Market, By Product, 2017–2024 (usD Million)
Table 4 Comparative Table of Commercially Available Insulin Pumps
Table 5 Electronic Wearable Infusion Pumps Market, By Region, 2017–2024 (USD Million)
Table 6 North America: Electronic Wearable Infusion Pumps Market, By Country, 2017–2024 (USD Million)
Table 7 Europe: Electronic Wearable Infusion Pumps Market, By Country, 2017–2024 (USD Million)
Table 8 Asia Pacific: Electronic Wearable Infusion Pumps Market, By Country, 2017–2024 (USD Million)
Table 9 RoW: Electronic Wearable Infusion Pumps Market, By Region, 2017–2024 (USD Million)
Table 10 Electronic Autoinjectors Market, By Region, 2017–2024 (USD Million)
Table 11 North America: Electronic Autoinjectors Market, By Country, 2017–2024 (USD Million)
Table 12 Europe: Electronic Autoinjectors Market, By Country, 2017–2024 (USD Million)
Table 13 Asia Pacific: Electronic Autoinjectors Market, By Country, 2017–2024 (USD Million)
Table 14 RoW: Electronic Autoinjectors Market, By Region, 2017–2024 (USD Million)
Table 15 Electronic Injection Pens Market, By Region, 2017–2024 (USD Million)
Table 16 North America: Electronic Injection Pens Market, By Country, 2017–2024 (USD Million)
Table 17 Europe: Electronic Injection Pens Market, By Country, 2017–2024 (USD Million)
Table 18 Asia Pacific: Electronic Injection Pens Market, By Country, 2017–2024 (USD Million)
Table 19 RoW: Electronic Injection Pens Market, By Region, 2017–2024 (USD Million)
Table 20 Electronic Inhalers Market, By Country, 2017–2024 (USD Million)
Table 21 Market, By Indication, 2017–2024 (USD Million)
Table 22 Top Five Countries With the Highest Number of Diabetics (20–79 Years), 2017 vs. 2045
Table 23 Electronic Drug Delivery Systems Market for Diabetes, By Region, 2017–2024 (USD Million)
Table 24 North America: Market for Diabetes, By Country, 2017–2024 (USD Million)
Table 25 Europe: Market for Diabetes, By Country, 2017–2024 (USD Million)
Table 26 Asia Pacific: Market for Diabetes, By Country, 2017–2024 (USD Million)
Table 27 RoW: Market for Diabetes, By Region, 2017–2024 (USD Million)
Table 28 Market for Multiple Sclerosis, By Region, 2017–2024 (USD Million)
Table 29 North America: Market for Multiple Sclerosis, By Country, 2017–2024 (USD Million)
Table 30 Europe: Market for Multiple Sclerosis, By Country, 2017–2024 (USD Million)
Table 31 Asia Pacific: Market for Multiple Sclerosis, By Country, 2017–2024 (USD Million)
Table 32 RoW: Market for Multiple Sclerosis, By Region, 2017–2024 (USD Million)
Table 33 Market for Cardiovascular Disease, By Region, 2017–2024 (USD Million)
Table 34 North America: Market for Cardiovascular Disease, By Country, 2017–2024 (USD Million)
Table 35 Europe: Market for Cardiovascular Disease, By Country, 2017–2024 (USD Million)
Table 36 Asia Pacific: Market for Cardiovascular Disease, By Country, 2017–2024 (USD Million)
Table 37 RoW: Market for Cardiovascular Disease, By Region, 2017–2024 (USD Million)
Table 38 Prevalence of COPD & Asthma in 2010 and 2016 (Million)
Table 39 Market for Asthma & COPD, By Country, 2017–2024 (USD Million)
Table 40 Market for Other Indications, By Region, 2017–2024 (USD Million)
Table 41 North America: Market for Other Indications, By Country, 2017–2024 (USD Million)
Table 42 Europe: Market for Other Indications, By Country, 2017–2024 (USD Million)
Table 43 Asia Pacific: Market for Other Indications, By Country, 2017–2024 (USD Million)
Table 44 RoW: Market for Other Indications, By Region, 2017–2024 (USD Million)
Table 45 Market, By Region, 2017–2024 (USD Million)
Table 46 Market, By Country, 2017–2024 (USD Million)
Table 47 North America: Market, By Country, 2017–2024 (USD Million)
Table 48 North America: Market, By Type, 2017–2024 (USD Million)
Table 49 North America: Market, By Indication, 2017–2024 (USD Million)
Table 50 US: Market, By Type, 2017–2024 (USD Million)
Table 51 US: Market, By Indication, 2017–2024 (USD Million)
Table 52 Canada: Market, By Type, 2017–2024 (USD Million)
Table 53 Canada: Market, By Indication, 2017–2024 (USD Million)
Table 54 Europe: Recent Developments in the Market, 2017–2018
Table 55 Europe: Market, By Country, 2017–2024 (USD Million)
Table 56 Europe: Market, By Type, 2017–2024 (USD Million)
Table 57 Europe: Market, By Indication, 2017–2024 (USD Million)
Table 58 Germany: Market, By Type, 2017–2024 (USD Million)
Table 59 Germany: Market, By Indication, 2017–2024 (USD Million)
Table 60 UK: Market, By Type, 2017–2024 (USD Million)
Table 61 UK: Market, By Indication, 2017–2024 (USD Million)
Table 62 France: Electronic Drug Delivery Systems Market, By Type, 2017–2024 (USD Million)
Table 63 France: Market, By Indication, 2017–2024 (USD Million)
Table 64 RoE: Market, By Type, 2017–2024 (USD Million)
Table 65 RoE: Market, By Indication, 2017–2024 (USD Million)
Table 66 Asia Pacific: Market, By Country, 2017–2024 (USD Million)
Table 67 Asia Pacific: Market, By Type, 2017–2024 (USD Million)
Table 68 Asia Pacific: Market, By Indication, 2017–2024 (USD Million)
Table 69 Japan: Market, By Type, 2017–2024 (USD Million)
Table 70 Japan: Market, By Indication, 2017–2024 (USD Million)
Table 71 China: Market, By Type, 2017–2024 (USD Million)
Table 72 China: Market, By Indication, 2017–2024 (USD Million)
Table 73 India: Market, By Type, 2017–2024 (USD Million)
Table 74 India: Market, By Indication, 2017–2024 (USD Million)
Table 75 RoAPAC: Market, By Type, 2017–2024 (USD Million)
Table 76 RoAPAC: Market, By Indication, 2017–2024 (USD Million)
Table 77 RoW: Market, By Region, 2017–2024 (USD Million)
Table 78 RoW: Market, By Type, 2017–2024 (USD Million)
Table 79 RoW: Market, By Indication, 2017–2024 (USD Million)
Table 80 Latin America: Market, By Type, 2017–2024 (USD Million)
Table 81 Latin America: Market, By Indication, 2017–2024 (USD Million)
Table 82 Middle East & Africa: Market, By Type, 2017–2024 (USD Million)
Table 83 Middle East & Africa: Market, By Indication, 2017–2024 (USD Million)
Table 84 Product Launches
Table 85 Expansions
Table 86 Agreements & Collaborations

List of Figures

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Electronic Drug Delivery Systems Market Share, By Type, 2018
Figure 7 Market Share, By Indication, 2018
Figure 8 Geographic Snapshot: stems Market, 2018
Figure 9 Growing Prevalence of Chronic Diseases is Likely to Drive the Market for Electronic Drug Delivery Systems
Figure 10 Electronic Wearable Infusion Pumps Accounted for the Largest Share of the North American Market in 2018
Figure 11 North America to Witness the Highest Growth During the Forecast Period
Figure 12 Market: Drivers, Restraints, Opportunities, & Challenges
Figure 13 Market, By Type, 2019 vs. 2024 (USD Million)
Figure 14 Market, By Indication, 2019 vs. 2024 (USD Million)
Figure 15 Market, By Region, 2019 vs. 2024
Figure 16 North America: Market Snapshot 65
Figure 17 Europe: Market Snapshot
Figure 18 Asia Pacific: Market Snapshot
Figure 19 RoW: Market Snapshot
Figure 20 Market Share Analysis By Key Players (2018)
Figure 21 Competitive Leadership Mapping: Market
Figure 22 Merck Group: Company Snapshot
Figure 23 Medtronic PLC: Company Snapshot
Figure 24 United Therapeutics Corporation: Company Snapshot
Figure 25 Insulet Corporation: Company Snapshot
Figure 26 Bayer AG: Company Snapshot
Figure 27 Exchange Rate (Utilized for the Conversion of Eur to USD)
Figure 28 Novo Nordisk: Company Snapshot
Figure 29 Tandem Diabetes Care, Inc.: Company Snapshot
Figure 30 F.Hoffmann-La Roche Ltd.: Company Snapshot
Figure 31 Amgen: Company Snapshot
Figure 32 Astrazeneca PLC: Company Snapshot

  • Global Pulmonary Drug Delivery Systems Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 143
    According to our LPI (LP Information) latest study, the global Pulmonary Drug Delivery Systems market size was valued at US$ 2979.8 million in 2023. With growing demand in downstream market, the Pulmonary Drug Delivery Systems is forecast to a readjusted size of US$ 4016.5 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Pulmonary Drug Delivery Systems market. Pulmonary Drug Delivery Systems are expected to show s......
  • Global Metered Dose Inhalers Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 88
    The Metered Dose Inhalers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metered Dose Inhalers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides pr......
  • Global Drug Delivery Devices Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151
    According to our LPI (LP Information) latest study, the global Drug Delivery Devices market size was valued at US$ 40490 million in 2023. With growing demand in downstream market, the Drug Delivery Devices is forecast to a readjusted size of US$ 57290 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Drug Delivery Devices market. Drug Delivery Devices are expected to show stable growth in the future market. However......
  • Global Nebulizers Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Nebulizers market size was valued at US$ 844.1 million in 2023. With growing demand in downstream market, the Nebulizers is forecast to a readjusted size of US$ 1194.4 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Nebulizers market. Nebulizers are expected to show stable growth in the future market. However, product differentiation, reducing costs, ......
  • Global Inhalation Therapy Nebulizer Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Inhalation Therapy Nebulizer market size was valued at US$ 1111.6 million in 2023. With growing demand in downstream market, the Inhalation Therapy Nebulizer is forecast to a readjusted size of US$ 1755.2 million by 2030 with a CAGR of 6.7% during review period. The research report highlights the growth potential of the global Inhalation Therapy Nebulizer market. Inhalation Therapy Nebulizer are expected to show stable growth......
  • Global Medical Nebulizer Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112
    According to our LPI (LP Information) latest study, the global Medical Nebulizer market size was valued at US$ 1082.4 million in 2023. With growing demand in downstream market, the Medical Nebulizer is forecast to a readjusted size of US$ 1836.1 million by 2030 with a CAGR of 7.8% during review period. The research report highlights the growth potential of the global Medical Nebulizer market. Medical Nebulizer are expected to show stable growth in the future market. However, product diff......
  • Global Intrathecal Pumps Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 75
    According to our LPI (LP Information) latest study, the global Intrathecal Pumps market size was valued at US$ 263.7 million in 2023. With growing demand in downstream market, the Intrathecal Pumps is forecast to a readjusted size of US$ 345.7 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Intrathecal Pumps market. Intrathecal Pumps are expected to show stable growth in the future market. However, product differ......
  • Global Intranasal Drug Delivery Devices Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Intranasal Drug Delivery Devices market size was valued at US$ 1118.1 million in 2023. With growing demand in downstream market, the Intranasal Drug Delivery Devices is forecast to a readjusted size of US$ 2382.3 million by 2030 with a CAGR of 11.4% during review period. The research report highlights the growth potential of the global Intranasal Drug Delivery Devices market. Intranasal Drug Delivery Devices are expected to s......
  • Global Drug Delivery Devices Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 156
    According to our (Global Info Research) latest study, the global Drug Delivery Devices market size was valued at USD 42590 million in 2023 and is forecast to a readjusted size of USD 58700 million by 2030 with a CAGR of 4.7% during review period. Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug ......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs